Last edition
News about "Abbott gets CDSCO approval for marketing of estrad"
Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC
Abbott, the global healthcare company, has received approval from the Subject Expert Committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of the fixed dose combination of dydrogesterone+estradiol (2.5 mg + 0.5mg) tablets
Abbott Gets CDSCO Approval For Marketing Of Estrad | 15/07/2021 | By Darshana | 434
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members